I disagree with your conclusion. The upcoming reverse split was required to uplist to the OTCBB, excellent financials, litigation settled, management answers phone, IR returns calls, web site updated. Metiscan was losing money, Aclor is making money. Night and day. Calling this a scam calls into question your motives and is not supported by anything we know.